myelodysplastic syndrome

Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Endpoints
Onconova
clinical trials
Rigosertib
myelodysplastic syndrome
Flag link:
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Pharmaceutical Business Review
Takeda Pharmaceuticals
breakthrough status
FDA
pevonedistat
myelodysplastic syndrome
Flag link:
This Cancer Drug Is Driving Forty Seven's Stock Higher
This Cancer Drug Is Driving Forty Seven's Stock Higher
Motley Fool
Forty Seven
magrolimab
clinical trials
myelodysplastic syndrome
Flag link:
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Flag link:
Celgene and Acceleron Submit BLA for Luspatercept
Celgene and Acceleron Submit BLA for Luspatercept
CP Wire
Celgene
Acceleron
luspatercept
myelodysplastic syndrome
beta thalassemia
Flag link:
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CP Wire
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Acceleron blood disease drug hits goal in pivotal clinical trial
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Flag link:
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Flag link:
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Aptevo
APVO436
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Geron Collaborates with J&J for Imetelstat
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Flag link:
Sunesis says encouraged by trial of Qinprezo
Sunesis says encouraged by trial of Qinprezo
The Fly on the Wall
Qinprexo
Sunesis
ASCO
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Can This Celgene Drug Defy the Patent Cliff?
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
patents
Celgene
myelodysplastic syndrome
Vidaza
Flag link:
Still Revving Up With Revlimid
Still Revving Up With Revlimid
Motley Fool
Revlimid
myelodysplastic syndrome
Multiple Myeloma
Celgene
Flag link:
What Is So Exciting About MEI Pharma?
What Is So Exciting About MEI Pharma?
Seeking Alpha
MEI Pharma
pracinostat
myelodysplastic syndrome
Flag link:
Cyclacel Heats Up On Clinical Trial Progression
Cyclacel Heats Up On Clinical Trial Progression
Seeking Alpha
Cyclacel
Sapacitabine
myelodysplastic syndrome
Flag link:
BioMarin Starts Study on BMN673
BioMarin Starts Study on BMN673
Yahoo/Zacks
Biomarin
BMN673
leukemia
lymphoma
myelodysplastic syndrome
Flag link:
Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
Yahoo/GlobeNewsWire
Cyclacel
Sapacitabine
acute myeloid leukemia
myelodysplastic syndrome
Flag link: